Presented at the Fifth Annual Conference on Vaccine Research, 6-8 May 2002, Baltimore, MD, USA (Abstract S45)
Warzecha et al. (2002) Oral immunogenicity of human papillomavirus virus-like particles expressed in potato. Presented at the Fifth Annual Conference on Vaccine Research, 6-8 May 2002, Baltimore, MD, USA (Abstract S45)
Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of virus-like particles
Rose R.C., et al. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67:1993;1936-1944.
Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies to human sera
Rose R.C., et al. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies to human sera. J. Gen. Virol. 75:1994;2075-2079.
Oral vaccination of mice with human papilomavirus virus-lie particles induces systemic virus-neutralizing antibodies
Rose R.C., et al. Oral vaccination of mice with human papilomavirus virus-lie particles induces systemic virus-neutralizing antibodies. Vaccine. 17:1999;2129-2135.
Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA
Gerber S., et al. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. J. Virol. 75:2001;4752-4760.
A Phase I study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers
Evans T.G., et al. A Phase I study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J. Infect. Dis. 183:2001;1485-1493.
Presented at the Fifth Annual Conference on Vaccine Research, 6-8 May 2002, Baltimore, MD, USA (Abstract S40)
Di Napoli, J. et al. (2002) Transdermal immunogenicity of human-papillomavirus-like particles administered in combination with E. coli LT(R192G). Presented at the Fifth Annual Conference on Vaccine Research, 6-8 May 2002, Baltimore, MD, USA (Abstract S40)
